merger | Science and Enterprise

Gene Therapy Biotech Acquired in $8.7 Billion Deal

By Alan, on April 9th, 2018%

A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion. . . . → Read More: Gene Therapy Biotech Acquired in $8.7 Billion Deal

Cancer Analytics Company Acquired in $1.9B Deal

By Alan, on February 16th, 2018%

The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion. . . . → Read More: Cancer Analytics Company Acquired in $1.9B Deal

Sanofi Buys Nano-Antibody Biotech in $4.8B Deal

By Alan, on January 29th, 2018%

Global drug maker Sanofi is acquiring a Belgian biotechnology company developing synthetic nanoscale therapeutic antibodies in a deal valued at $4.8 billion. . . . → Read More: Sanofi Buys Nano-Antibody Biotech in $4.8B Deal

Blood Disorder Drug Maker Acquired in $11.6B Deal

By Alan, on January 22nd, 2018%

The global pharmaceutical company Sanofi is buying Bioverativ Inc., a developer of biologics to treat hemophilia and other rare blood disorders. . . . → Read More: Blood Disorder Drug Maker Acquired in $11.6B Deal

Celgene Acquires Cancer Drug Start-Up in $7B Deal

By Alan, on January 8th, 2018%

The biopharmaceutical company Celgene Corp. is acquiring Impact Biomedicines Inc., a developer of drugs to treat a type of blood-related cancer, in a deal valued as much as $7 billion. . . . → Read More: Celgene Acquires Cancer Drug Start-Up in $7B Deal

Novartis Acquires Nuclear Meds Developer in $3.9B Deal

By Alan, on October 30th, 2017%

Drug maker Novartis is purchasing a company that develops therapies and diagnostics using radio isotopes for neuroendocrine and other cancers. . . . → Read More: Novartis Acquires Nuclear Meds Developer in $3.9B Deal

Infographic – Google’s Largest Acquisitions

By Alan, on September 23rd, 2017%

Our friends at Statista yesterday published this chart showing Google/Alphabet’s largest acquisitions over the years. . . . → Read More: Infographic – Google’s Largest Acquisitions

Engineered T-Cell Company Acquired for $11.9 Billion

By Alan, on August 28th, 2017%

A company developing personal cancer therapies that genetically engineer a patient’s immune system cells is being acquired in a deal valued at $11.9 billion. . . . → Read More: Engineered T-Cell Company Acquired for $11.9 Billion

Genomics Company Acquires Open-Source Biomedical Platform

By Alan, on August 3rd, 2017%

A company providing whole genome analysis is acquiring an enterprise developing open-source computational software for biomedical uses, such as precision medicine. . . . → Read More: Genomics Company Acquires Open-Source Biomedical Platform

Lilly Acquires Migraine Therapy Company in $960M Deal

By Alan, on January 19th, 2017%

Drug maker Eli Lilly and Company is acquiring CoLucid Pharmaceuticals, a developer of treatments for migraine pain and associated symptoms. . . . → Read More: Lilly Acquires Migraine Therapy Company in $960M Deal

Science & Enterprise subscription

Guest Posts

Please share Science & Enterprise

Specials

Affiliations

Gene Therapy Biotech Acquired in $8.7 Billion Deal

Cancer Analytics Company Acquired in $1.9B Deal

Sanofi Buys Nano-Antibody Biotech in $4.8B Deal

Blood Disorder Drug Maker Acquired in $11.6B Deal

Celgene Acquires Cancer Drug Start-Up in $7B Deal

Novartis Acquires Nuclear Meds Developer in $3.9B Deal

Infographic – Google’s Largest Acquisitions

Engineered T-Cell Company Acquired for $11.9 Billion

Genomics Company Acquires Open-Source Biomedical Platform

Lilly Acquires Migraine Therapy Company in $960M Deal

Welcome to Science & Enterprise

Here’s what’s new …

Follow us on Facebook

Alan Kotok’s articles on

Search by tag